Impact of Endometrial Compaction in Euploid Frozen Embryo Transfers
1 other identifier
observational
187
1 country
1
Brief Summary
The purpose of this pilot study is to evaluate whether a decrease in endometrial thickness (compaction) prior to progesterone exposure (endogenous or exogenous) to the day before a single frozen embryo transfer has an impact on the clinical pregnancy rate with euploid embryos in exogenous hormone and modified natural thaw cycles. Information derived from this study may give insight on ways to improve pregnancy rates in cryo-thaw cycles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2020
CompletedFirst Posted
Study publicly available on registry
April 1, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMarch 11, 2022
March 1, 2022
1.7 years
March 30, 2020
March 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical pregnancy rate
defined as confirmation of gestational sac with fetal heart beat on ultrasound between 6 - 9 weeks gestation
through study completion, an average of 1 year
Secondary Outcomes (3)
Biochemical pregnancy rate
through study completion, an average of 1 year
Live birth rate
through study completion, an average of 1 year
Miscarriage rate
through study completion, an average of 1 year
Study Arms (2)
Exogenous hormone replacement thaw cycle
Participants in this group will follow Boston IVF's standard exogenous hormone replacement protocol. Participants will take Estrace 3mg twice daily by mouth for endometrial preparation. After 16-18 days of Estrace, endometrial thickness will be measured by transvaginal ultrasound but medication and ultrasounds will be continued until the endometrial lining is ≥ 7 mm. Once the final endometrial lining is ≥ 7 mm (T1), the doctor of record will start the participant the following day with intramuscular progesterone daily or intramuscular progesterone every 3 days with daily vaginal progesterone. Frozen embryo transfers would occur on the sixth day of progesterone.
Natural thaw cycle
Participants in this group will follow Boston IVF's standard natural thaw cycle protocol. Participants will be coming for blood and transvaginal ultrasound monitoring around day 11 of the participants cycle. Once the participant has a final measurement of the endometrial lining ≥ 7 mm (T1), a 17mm ovarian follicle, and a progesterone \< 1.2 ng/mL, the doctor of record will schedule the patient to receive a trigger injection to induce ovulation followed by an embryo transfer 6-7 days later. Participants may be started on vaginal progesterone 4 days after the trigger injection for added supplementation per the doctor of record.
Interventions
On the day of the participants frozen embryo transfer, an endometrial thickness measurement (T2) will obtained from an abdominal ultrasound during the embryo transfer.
Eligibility Criteria
Participants that are having a single frozen embryo transfer with a euploid embryo.
You may qualify if:
- Single euploid frozen embryo transfer
- ≥ 7 mm endometrial lining on transvaginal ultrasound
- st or 2nd frozen embryo transfer
You may not qualify if:
- Obesity with body mass index \> 40
- Underweight with body mass index \< 18.5
- Utilization of a gestational carrier
- History of recurrent pregnancy loss (≥ 2 spontaneous abortions)
- Uterine factors (history of uterine adhesions, uterine surgery, fibroids, polyps)
- History of an endometrial receptivity assay (ERA) biopsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston IVFlead
Study Sites (1)
Boston IVF
Boston, Massachusetts, 02109, United States
Related Publications (1)
Shah JS, Vaughan DA, Dodge LE, Leung A, Korkidakis A, Sakkas D, Ryley DA, Penzias AS, Toth TL. Endometrial compaction does not predict live birth in single euploid frozen embryo transfers: a prospective study. Hum Reprod. 2022 May 3;37(5):980-987. doi: 10.1093/humrep/deac060.
PMID: 35357436DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan Penzias, MD
Boston IVF
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2020
First Posted
April 1, 2020
Study Start
September 1, 2020
Primary Completion
May 30, 2022
Study Completion
June 30, 2022
Last Updated
March 11, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share